Table 2.
Patient | Completed (Y/N) | # of treatments | Time to response | Baseline BPRS | Post BPRS | BPRS % improvement | Baseline QoL | Post QoL | QoL % improvement | Frequency (Hz) |
---|---|---|---|---|---|---|---|---|---|---|
1 | Y | 24 | NR | 40 | 32 | 20% | 40 | 58 | 18% | 100 |
2 | Y | 6 | 3 | 40 | 22 | 45% | 52 | 88 | 36% | 50 |
3 | N | 12 | NR | 44 | 36 | 18% | 52 | – | – | 50 |
4 | N | 6 | NR | 38 | 43 | −13% | 61 | – | – | 25 |
5 | Y | 24 | 9 | 42 | 24 | 43% | 38 | 68 | 30% | 25 |
6 | N | 12 | NR | 45 | 46 | −2% | 11 | – | – | 25 |
7 | N | 23 | 6 | 52 | 32 | 38% | 16 | 36 | 26% | 60 |
8 | Y | 18 | 9 | 40 | 24 | 40% | 48 | 54 | 6% | 60 |
NR, no response; BPRS, Brief Psychiatric Rating Scale; QoL, quality of life assessed by Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q SF), reported as percentage of maximum possible score; frequency, magnetic seizure therapy stimulation used to achieve therapeutic seizures.